Nephroplus Dispatches Annual Report FY26 & AGM Notice; AGM on Aug 12
Nephroplus dispatched its Annual Report FY26 and AGM Notice on July 16, 2026. The 17th AGM is scheduled for August 12, 2026, at 2:30 PM IST via VC/OAVM. The cut-off date is August 5, 2026, with remote e-voting from August 8 to August 11, 2026.
This is a standard procedural announcement related to corporate governance and regulatory compliance, with no immediate material impact on the company's business or stock.
The announcement is a routine corporate communication regarding the dispatch of the annual report and AGM notice, with no significant financial or operational updates.
Nephrocare Health Services Limited (Nephroplus) has completed the dispatch of a letter providing a web-link to its Annual Report for the financial year 2025-26, along with the Notice for the 17th Annual General Meeting (AGM). This dispatch was completed on July 16, 2026, and was sent to members who have not registered their email addresses with the company or its registrars. The company has also made the newspaper publications and the Annual Report available on its website, www.nephroplus.com.
The 17th AGM of the Members of Nephrocare Health Services Limited is scheduled to be held on Wednesday, August 12, 2026, at 02:30 PM IST. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in compliance with applicable regulations. The cut-off date for determining the eligibility of members to attend and vote at the AGM is Wednesday, August 5, 2026. Book closure will be from Thursday, August 06, 2026, to Wednesday, August 12, 2026, inclusive. Remote e-voting will commence on Saturday, August 8, 2026, at 09:00 AM IST and conclude on Tuesday, August 11, 2026, at 05:00 PM IST. The Annual Report 2025-26 and the AGM Notice can be accessed via a provided web-link and are also available on the websites of BSE and NSE.
What to do with a filing like this
Nephrocare Health Services Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nephrocare Health Services Limited. Read the original for the full detail.